Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Alessandro Gronchi, Javier Martín‐Broto, Silvia Stacchiotti et al.|Annals of Oncology|2021Cited by 978
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Beate Timmermann, Stefan Bielack et al.|European Journal of Cancer|2019Cited by 724
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upPaolo G. Casali, Ofer Merimsky, Stefan Bielack et al.|Annals of Oncology|2018Cited by 641
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa Marina, Lisa A. Teot, Sigbjørn Smeland et al.|The Lancet Oncology|2016Cited by 537
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-upSandra J. Strauss, Anna Maria Frezza, N. Abecassis et al.|Annals of Oncology|2021Cited by 453